PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28381659-0	2017	A strategy to improve the success rate of CNS drug development: TAK-063, a novel PDE10A inhibitor, as a case study.	1-(2-fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one	64-71	phosphodiesterase 10A	Homo sapiens	81-87